Greenlight Biosciences Welcomes Thomas Crampton as Senior Vice President for Corporate Affairs
News provided by
Share this article
Share this article
BOSTON, Jan. 27, 2021 /PRNewswire/ GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design and manufacturing for human, animal and plant health, today announced the appointment of Thomas Crampton as the company s Senior Vice President for Corporate Affairs. Regulatory approvals last year moved RNA vaccines from the realm of scientific theory to medical reality and made them a core tool to combat the COVID-19 pandemic, said Charles Cooney, Chairman of GreenLight s board. Thomas brings the strategic experience, global outlook and leadership skills to scale GreenLight s ambition to match the transformative potential for RNA across life sciences, agriculture and beyond.